Pfizer Shares Rise on Celebrex, Aleve Trial Data
261035
Pfizer Inc. shares rebounded on Tuesday as a study of Alzheimer&#39;s patients found that its arthritis drug Celebrex carried no increased cardiovascular risks, differing from
302848
U.S. stocks rose on Monday as a slew of acquisition deals pointed to optimism about the economy, outweighing sharp losses by blue-chip Pfizer Inc. , which dropped a key experimental drug.
482981
NEW YORK - Pfizer Inc. said it found an increased risk of heart attacks for patients taking high dosages of its top-selling painkiller Celebrex, the same problem that led to the withdrawal of its one-time competitor Vioxx.
494835
Shares of drug company AtheroGenics Inc. opened up 81 percent Tuesday morning and remained at high levels after the company revealed promising clinical data late Monday for a drug to treat hardening arteries.
64597
Pfizer Inc. on Friday reported an increased risk of heart problems among patients taking high doses of its popular painkiller and arthritis drug Celebrex.
511457
Pfizer Inc. PFE.N, the world's  largest drug company, on Wednesday said fourth-quarter earnings  rose on strong sales of cholesterol treatment Lipitor and  arthritis drug Celebrex.
422768
Pfizer reaffirmed its commitment today to Celebrex, its blockbuster prescription medication for pain and inflammation from arthritis.
725823
NEW YORK/GROTON, Connecticut  - Pfizer Inc.  raised its 2006 profit forecast on Thursday and said its roster of experimental drugs in late-stage testing could triple by 2009, sending its shares higher.
471595
U.S. stocks rose on Wednesday, a day  after the blue-chip Dow hit a 3-1/2 year high, as oil prices  tumbled more than a dollar and battered-down drug stock Pfizer  Inc PFE.N rose nearly 4 percent.
257790
Celebrex, a huge-selling painkiller sold by Pfizer, more than tripled the risk of heart attacks, strokes and death among those taking high doses in a national trial, the company said Friday.
692786
NEW YORK - Pfizer Inc. said Wednesday that third quarter earnings, excluding charges, beat Wall Street expectations by a penny, on strong sales of Lipitor and Celebrex medicines.
417741
Pfizer Inc. PFE.N on Wednesday said  third-quarter earnings rose on higher sales of cholesterol and  arthritis drugs, but the company cautioned that 2005 results  will likely be hurt by generic competition for four other  popular medicines.
138871
We have today been informed of new clinical trial data for celecoxib (Celebrex), showing an increased risk of heart attack, stroke and death (relative to placebo).
363593
Oil prices held steady above &#36;46 and most Asian stock markets edged higher on Monday, but Japanese pharmaceutical shares fell after U.S. drug maker Pfizer reported safety risks for its Celebrex arthritis drug.
464864
Pfizer Inc , the world's  biggest drugmaker, on Wednesday reported fourth-quarter results  that beat expectations.
212952
Pfizer Inc.  on Thursday said  second-quarter earnings from continuing operations rose about  13 percent on higher sales of medicines like cholesterol  fighter Lipitor and Celebrex for arthritis.
445497
Pfizer said that it would sponsor a major clinical trial of Celebrex, its prescription arthritis pain medication, to assess the cardiovascular benefits of the drug.